ArticleScience advances2025
Ultrasoft hydrogel immune millirobot with multimodal locomotion.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Microrobots for Precision Diagnosis and Treatment in the Digestive System: A Review of Actuation Mechanisms, Structural Design, Preclinical and Translational Applications.Micromachines · 2026Review
- Ionic weaving network enables mechanically robust smart hydrogels with anti-swelling and anti-freezing capabilities.Nature communications · 2026Article
- MOF-Induced Pore Confinement: A Strategy for Thermomechanically Robust and High-Strength Liquid Crystal Elastomers.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Autonomous Microrobots for Spatiotemporally Active Therapeutic Delivery and Controlled Release.Cyborg and bionic systems (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advancements in cellular immunotherapy demanded efficient immune cell delivery. To meet this need, we introduced hydrogel-based immune millirobots designed for high immune cell loading and precise tumor targeting. These ultrasoft robots, embedded with magnetic nanoparticles, exhibited adaptable locomotion: walking, rolling, climbing, and undulating, enabling navigation through complex biological environments and alignment with varied tumor morphologies. They responded to magnetic fields and ionic or pH changes, facilitating propulsion, grasping, and localized delivery. In vitro, the millirobots eradicated three-dimensional tumor models in four days; in vivo, they notably reduced tumor growth in HepG2-luc tumor-bearing nude mice within 15 days. Bioluminescence imaging confirmed enhanced natural killer cell activity at tumor sites. The robots demonstrated excellent biocompatibility and biodegradability and caused no adverse effects postimplantation. This work showcased a responsive, soft robotic system with potential for advancing immune cell delivery and exploring tumor-immune dynamics in cancer therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.